DeAngelo, D. J., Schuh, A. C., Jonas, B. A., Becker, P. S., Advani, A. S., Uy, G. L., … Montesinos, P. (2024). Efficacy and Safety of Uproleselan Combined with Chemotherapy Vs. Chemotherapy Alone in Relapsed/Refractory Acute Myeloid Leukemia: Findings from an International Phase 3 Trial. In Blood (Vol. 144, pp. 733–733). American Society of Hematology. https://doi.org/10.1182/blood-2024-209097

DeAngelo, Daniel J., Andre C. Schuh, Brian A. Jonas, Pamela S. Becker, Anjali S. Advani, Geoffrey L. Uy, Janusz Krawczyk, et al. “Efficacy and Safety of Uproleselan Combined with Chemotherapy Vs. Chemotherapy Alone in Relapsed/Refractory Acute Myeloid Leukemia: Findings from an International Phase 3 Trial.” In Blood, 144:733–733. American Society of Hematology, 2024. https://doi.org/10.1182/blood-2024-209097.

DeAngelo DJ, Schuh AC, Jonas BA, Becker PS, Advani AS, Uy GL, et al. Efficacy and Safety of Uproleselan Combined with Chemotherapy Vs. Chemotherapy Alone in Relapsed/Refractory Acute Myeloid Leukemia: Findings from an International Phase 3 Trial. In: Blood. American Society of Hematology; 2024. p. 733–733.

DeAngelo, Daniel J., et al. “Efficacy and Safety of Uproleselan Combined with Chemotherapy Vs. Chemotherapy Alone in Relapsed/Refractory Acute Myeloid Leukemia: Findings from an International Phase 3 Trial.” Blood, vol. 144, no. Supplement 1, American Society of Hematology, 2024, pp. 733–733. Crossref, doi:10.1182/blood-2024-209097.

DeAngelo DJ, Schuh AC, Jonas BA, Becker PS, Advani AS, Uy GL, Krawczyk J, Erba HP, Mannis GN, Fong CY, Kuchenbauer F, Percival M-EM, Liesveld JL, Blum W, Cooper BW, Mims A, Lanza F, Janssen JJWM, Bergua Burgues JM, Kovacsovics T, Vey N, Hemmer MV, Bonifacio G, Rock E, Montesinos P. Efficacy and Safety of Uproleselan Combined with Chemotherapy Vs. Chemotherapy Alone in Relapsed/Refractory Acute Myeloid Leukemia: Findings from an International Phase 3 Trial. Blood. American Society of Hematology; 2024. p. 733–733.